Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Dapsone Gel 7.5% in Mild-to-Moderate Acne Vulgaris
NCT07244887Phase 4Completed
- Start
- Jun 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapsone in acne vulgaris. Started Jun 2025; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07244887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07244887.